14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antimicrobial stewardship in Scotland: impact of a national programme

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Backgound

          The Scottish Antimicrobial Prescribing Group (SAPG) was established by the Scottish Government in 2008 to lead the first national initiative to actively address antimicrobial stewardship. Healthcare associated infection (HAI) is a priority in Scotland and the work of SAPG contributes to the national HAI Delivery Plan. SAPG's early work has focused on restricting the use of antibiotics associated with a high risk of Clostridium difficile infection (CDI) and development of national prescribing indicators to support reduction of CDI.

          Findings

          Scottish Antimicrobial Prescribing Group has developed prescribing indicators for hospital and primary care, which are measured and reported in all 14 NHS board areas. Improvement in compliance with the indicators has been demonstrated with resultant reductions in CDI rates and no adverse effect on mortality or antimicrobial resistance patterns.

          Conclusions

          The establishment of a Scottish national antimicrobial stewardship programme has made a significant contribution to the HAI agenda, particularly in relation to CDI. The programme is supported by local antimicrobial teams, a national framework for education, surveillance of antimicrobial use and resistance and sharing of data for improvement. Antimicrobial stewardship has been integrated with other national programmes on patient safety and quality improvement.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Economic healthcare costs of Clostridium difficile infection: a systematic review.

          Clostridium difficile infection (CDI) is the leading cause of infectious diarrhoea in hospitalised patients. CDI increases patient healthcare costs due to extended hospitalisation, re-hospitalisation, laboratory tests and medications. However, the economic costs of CDI on healthcare systems remain uncertain. The purpose of this study was to perform a systematic review to summarise available studies aimed at defining the economic healthcare costs of CDI. We conducted a literature search for peer-reviewed studies that investigated costs associated with CDI (1980 to present). Thirteen studies met inclusion and exclusion criteria. CDI costs in 2008 US dollars were calculated using the consumer price index. The total and incremental costs for primary and recurrent CDI were estimated. Of the 13, 10 were from the USA and one each from Canada, UK, and Ireland. In US-based studies incremental cost estimates ranged from $2,871 to $4,846 per case for primary CDI and from $13,655 to $18,067 per case for recurrent CDI. US-based studies in special populations (subjects with irritable bowel disease, surgical inpatients, and patients treated in the intensive care unit) showed an incremental cost range from $6,242 to $90,664. Non-US-based studies showed an estimated incremental cost of $5,243 to $8,570 per case for primary CDI and $13,655 per case for recurrent CDI. Economic healthcare costs of CDI were high for primary and recurrent cases. The high cost associated with CDI justifies the use of additional resources for CDI prevention and control. Copyright (c) 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
            Bookmark

            Author and article information

            Journal
            Antimicrob Resist Infect Control
            Antimicrob Resist Infect Control
            Antimicrobial Resistance and Infection Control
            BioMed Central
            2047-2994
            2012
            3 February 2012
            : 1
            : 7
            Affiliations
            [1 ]Ninewells Hospital & Medical School, Dundee, DD19SY, UK
            [2 ]Scottish Medicines Consortium, Delta House, 50 West Nile Street, Glasgow G1 2NP, UK
            [3 ]Healthcare Improvement Scotland, Elliott House, 8-10 Hillside Crescent, Edinburgh EH7 5EA, UK
            [4 ]NHS National Services Scotland, Health Protection Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE, UK
            Article
            2047-2994-1-7
            10.1186/2047-2994-1-7
            3436612
            22958296
            977ef7c1-d43b-4936-848d-26aa97f684fc
            Copyright ©2012 Nathwani et al; licensee BioMed Central Ltd.

            This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            History
            : 3 January 2012
            : 3 February 2012
            Categories
            Short Report

            Infectious disease & Microbiology
            antimicrobial stewardship,quality improvement,prescribing indicators,clostridium difficile infection

            Comments

            Comment on this article